FDA — authorised 13 February 2009
- Application: NDA021856
- Marketing authorisation holder: TAKEDA PHARMS USA
- Local brand name: ULORIC
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Febuxostat IR in United States
FDA authorised Febuxostat IR on 13 February 2009
Marketing authorisation
Frequently asked questions
Is Febuxostat IR approved in United States?
Yes. FDA authorised it on 13 February 2009.
Who is the marketing authorisation holder for Febuxostat IR in United States?
TAKEDA PHARMS USA holds the US marketing authorisation.